Bilaketaren emaitzak - Daigo Hashimoto

Separation of GVL from GVHD -location, location, location nork Takanori Teshima, Daigo Hashimoto

Testu osoa

Calcineurin inhibitor blocks tolerance by suppressing donor T cell terminal exhaustion after allogeneic hematopoietic cell transplantation nork Hajime Senjo, Daigo Hashimoto, Takanori Teshima

Testu osoa

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease nork Yuta Hasegawa, Takanori Teshima, Daigo Hashimoto

Testu osoa

HokUS-10 scoring system predicts the treatment outcome for sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation nork Souichi Shiratori, Kohei Okada, Junichi Sugita, Mutsumi Nishida, Takahito Iwai, Shuichi Ota, Daigo Hashimoto, Takanori Teshima

Testu osoa

P1526: THE RISK OF DEVELOPING PNEUMOCYSTIS JIROVECII PNEUMONIA PERSISTS EVEN AFTER COMPLETION OF IMMUNOSUPPRESSANTS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS nork Takahide Ara, Shota Yokoyama, Yuta Hasegawa, Hiroyuki Ohigashi, Toshihiro Matsukawa, Atushi Yasumoto, Souichi Shiratori, Hideki Goto, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshima

Testu osoa

Myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease nork Satomi Matsuoka, Daigo Hashimoto, Masanori Kadowaki, Hiroyuki Ohigashi, Eiko Hayase, Emi Yokoyama, Yuta Hasegawa, Takahiro Tateno, Xuanzhong Chen, Kazutoshi Aoyama, Hideyo Oka, Masahiro Onozawa, Kiyoshi Takeda, Koichi Akashi, Takanori Teshima

Testu osoa

P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY nork Shota Yokoyama, Takahide Ara, Shinpei Harada, Yuto Mori, Yuta Hasegawa, Hiroyuki Ohigashi, Toshihiro Matsukawa, Atsushi Yasumoto, Souichi Shiratori, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, Hideki Goto, Takanori Teshima

Testu osoa

P1261: NEGATIVE IMPACT OF HLA-B LEADER MISMATCH ON OUTCOMES OF HCT WITH PTCY FOR LYMPHOID MALIGNANCIES: A RETROSPECTIVE ANALYSIS FROM THE JAPANESE SOCIETY FOR TRANSPLANTATION AND C... nork Minoru Kanaya, Daigo Hashimoto, Hirohisa Nakamae, Takahide Ara, Takahiro Fukuda, Koji Nagafuji, Tetsuya Eto, Nobuhiro Hiramoto, Yumiko Maruyama, Shuichi Ota, Ken-Ichi Matsuoka, Takashi Akasaka, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Testu osoa

Serum level of soluble interleukin‐2 receptor is positively correlated with metabolic tumor volume on 18F‐FDG PET/CT in newly diagnosed patients with diffuse large B‐cell lymphoma nork Hajime Senjo, Minoru Kanaya, Koh Izumiyama, Koichiro Minauchi, Kenji Hirata, Akio Mori, Makoto Saito, Masanori Tanaka, Hiroaki Iijima, Eriko Tsukamoto, Kazuo Itoh, Shuichi Ota, Masanobu Morioka, Daigo Hashimoto, Takanori Teshima, North Japan Hematology Study Group (NJHSG)

Testu osoa

Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy nork Kohei Kasahara, Masahiro Onozawa, Naohiro Miyashita, Emi Yokohata, Miho Yoshida, Minoru Kanaya, Mizuha Kosugi-Kanaya, Ryo Takemura, Shojiro Takahashi, Junichi Sugita, Akio Shigematsu, Mutsumi Takahata, Shinichi Fujisawa, Daigo Hashimoto, Katsuya Fujimoto, Tomoyuki Endo, Takeshi Kondo, Takanori Teshima

Testu osoa

Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell tr... nork Hiroki Nishikawa, Shunsuke Ohnishi, Hiroshi Hayashi, Rika Okamoto, Kenichi Yamahara, Toshiyuki Isoe, Norihiro Sato, Akiko Hamada, Toshihiro Soma, Masaya Okada, Satoshi Yoshihara, Kyoko Yoshihara, Kazuhiro Ikegame, Hiroya Tamaki, Katsuji Kaida, Takayuki Inoue, Yuko Ohsugi, Hiroaki Iijima, Daigo Hashimoto, Takanori Teshima, Hiroyasu Ogawa, Yoshihiro Fujimori

Testu osoa

Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes nork Toshihiro Matsukawa, Shota Yoshida, Masahiro Onozawa, Fumiaki Fujii, Jun Nagai, Tomoki Takahashi, Shuichi Ota, Junichi Hashiguchi, Akio Mori, Takuto Miyagishima, Makoto Ibata, Yasutaka Kakinoki, Tatsuo Oyake, Satoshi Yamamoto, Toshiaki Hayashi, Kentaro Wakasa, Tomoyuki Saga, Tetsuya Igarashi, Satoshi Iyama, Yutaka Tsutsumi, Katsuya Fujimoto, Masaaki Adachi, Masahiro Yoshida, Daigo Hashimoto, Takanori Teshima

Testu osoa

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study nork Nirav N. Shah, Pier Luigi Zinzani, Michael Wang, Sunita D. Nasta, Ewa Lech-Maranda, Yoshiaki Ogawa, Bita Fakhri, Bryone Kuss, Kaname Miyashita, Krish Patel, Catherine C. Coombs, Shuo Ma, Manish R. Patel, Minal A. Barve, Benoit Tessoulin, Anastasios Stathis, Daisuke Ennishi, Daigo Hashimoto, Kensuke Kojima, Andrew D. Zelenetz, Jonathon B. Cohen, Julie M. Vose, Kami J. Maddocks, Talha Munir, Fangfang Sun, Yuanyuan Bian, Minna Balbas, Donald E. Tsai, Paolo Abada, Chan Y. Cheah

Testu osoa